What We Do
Founded in 1997, we are a niche CRO with a singular focus in oncology clinical trials (Phase 1, 2 & Phase 3). With privileged site relationships across Canada we help small & mid-sized biopharma clients achieve the following study activities.

Site Selection &
Accelerated Study
Start-Up

Health Canada
Regulatory
Strategy

Provincial Ethics
Approval Strategy
(IRB/REB)

Clinical
Monitoring

Country
Oversight

REVERSE FEASIBILITY PROGRAM
A powerful approach to feasibility assessment that is proven to accelerate start-up by connecting sponsors with a network of top performing Canadian oncology investigators.
